Back to Search Start Over

TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition?

Authors :
Cumbo C
Orsini P
Tarantini F
Anelli L
Zagaria A
Tragni V
Coccaro N
Tota G
Parciante E
Conserva MR
Redavid I
Minervini CF
Minervini A
Attolico I
Gentile M
Pierri CL
Specchia G
Musto P
Albano F
Source :
Hematological oncology [Hematol Oncol] 2023 Dec; Vol. 41 (5), pp. 942-946. Date of Electronic Publication: 2023 Aug 03.
Publication Year :
2023

Abstract

TNFRSF13B mutations are widely associated with common variable immunodeficiency. TNFRSF13B was recently counted among relevant genes associated with childhood-onset of hematological malignancies; nonetheless, its role in acute myeloid leukemia (AML) remains unexplored. We report the study of a family with two cases of AML, sharing a germline TNFRSF13B mutation favoring the formation of a more stable complex with its ligand TNFSF13: a positive regulator of AML-initiating cells. Our data turn the spotlight onto the TNFRSF13B role in AML onset, inserting a new fragment into the complex scenario of a hereditary predisposition to myeloid neoplasms.<br /> (© 2023 The Authors. Hematological Oncology published by John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1099-1069
Volume :
41
Issue :
5
Database :
MEDLINE
Journal :
Hematological oncology
Publication Type :
Report
Accession number :
37534633
Full Text :
https://doi.org/10.1002/hon.3212